Stable Istotope Labelled Domagrozumab Biosimilar – Anti-MSTN /GDF8 mAb – Research Grade

Reference: PX-TA1426-SIL-1MG
Product nameStable Istotope Labelled Domagrozumab Biosimilar - Anti-MSTN /GDF8 mAb - Research Grade
SourceCAS 1629605-31-7
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPF-06252616
ReferencePX-TA1426-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-MSTN /GDF8[Homo sapiens] (Domagrozumab) Monoclonal Antibody

Domagrozumab is investigated for the treatment of Duchenne muscular dystrophy (DMD).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Domagrozumab Biosimilar – Anti-MSTN /GDF8 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.